| Min Pa: | Min Pa(max): | Activity's type: |
| Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |
|---|---|---|---|---|---|---|
| 0.526 | 0.019 | 0.526 | Calcium channel L-type activator | 0.522 0.02 CID_46780317 0.408 0.076 CID_154699645 | ||
| 0.495 | 0.024 | 0.495 | Aryl hydrocarbon receptor agonist | 0.327 0.054 CID_46780317 0.152 0.134 CID_154699645 | ||
| 0.47 | 0.024 | 0.609 | Glucose-6-phosphate dehydrogenase-6-phosphogluconolactonase inhibitor | 0.609 0.009 CID_46780317 0.469 0.024 CID_154699645 | CID_46780317 | |
| 0.436 | 0.021 | 0.436 | Superoxide dismutase inhibitor | 0.419 0.023 CID_46780317 0.205 0.112 CID_154699645 | ||
| 0.42 | 0.018 | 0.42 | Calcium channel activator | 0.401 0.024 CID_46780317 0.295 0.097 CID_154699645 | ||
| 0.453 | 0.06 | 0.453 | Ca2+/calmodulin-dependent protein kinase kinase A inhibitor | 0.3 0.213 CID_46780317 0.422 0.082 CID_154699645 | ||
| 0.459 | 0.078 | 0.462 | Caspase 9 stimulant | 0.462 0.077 CID_46780317 0.365 0.134 CID_154699645 | CID_46780317 | |
| 0.422 | 0.047 | 0.422 | MAP kinase kinase 6 inhibitor | 0.346 0.096 CID_46780317 0.332 0.107 CID_154699645 | ||
| 0.36 | 0.009 | 0.36 | Interleukin 6 antagonist | 0.287 0.017 CID_46780317 | ||
| 0.345 | 0.004 | 0.432 | Potassium channel (Ca-activated) activator | 0.432 0.004 CID_46780317 0.13 0.036 CID_154699645 | CID_46780317 | |
| 0.372 | 0.037 | 0.372 | Interleukin 2 agonist | 0.301 0.073 CID_46780317 | ||
| 0.37 | 0.075 | 0.37 | GABA C receptor rho-3 antagonist | 0.335 0.094 CID_46780317 | ||
| 0.292 | 0.009 | 0.292 | MAP kinase kinase 3 inhibitor | 0.234 0.05 CID_46780317 | ||
| 0.36 | 0.082 | 0.377 | Calpain 2 inhibitor | 0.377 0.073 CID_46780317 | CID_46780317 | |
| 0.282 | 0.008 | 0.282 | Androgen antagonist | 0.23 0.011 CID_46780317 0.176 0.017 CID_154699645 | ||
| 0.274 | 0.005 | 0.421 | Potassium channel large-conductance Ca-activated activator | 0.421 0.004 CID_46780317 0.1 0.024 CID_154699645 | CID_46780317 | |
| 0.26 | 0.005 | 0.26 | Potassium channel activator | 0.242 0.005 CID_46780317 0.149 0.021 CID_154699645 | ||
| 0.264 | 0.009 | 0.264 | Adenylate kinase inhibitor | 0.231 0.011 CID_46780317 0.147 0.028 CID_154699645 | ||
| 0.266 | 0.023 | 0.277 | Nitric-oxide synthase stimulant | 0.277 0.018 CID_46780317 0.217 0.064 CID_154699645 | CID_46780317 | |
| 0.243 | 0.004 | 0.243 | Kainate receptor antagonist | 0.116 0.006 CID_46780317 0.065 0.014 CID_154699645 | ||
| 0.243 | 0.004 | 0.243 | AMPA receptor antagonist | 0.138 0.007 CID_46780317 0.076 0.018 CID_154699645 | ||
| 0.25 | 0.012 | 0.258 | Mannose-6-phosphate isomerase inhibitor | 0.258 0.01 CID_46780317 0.184 0.04 CID_154699645 | CID_46780317 | |
| 0.296 | 0.059 | 0.296 | DNA damaging | 0.208 0.109 CID_46780317 | ||
| 0.25 | 0.013 | 0.253 | UDP-glucose 4-epimerase inhibitor | 0.253 0.013 CID_46780317 0.156 0.027 CID_154699645 | CID_46780317 | |
| 0.319 | 0.086 | 0.331 | Transcription factor NF kappa B inhibitor | 0.331 0.083 CID_46780317 | CID_46780317 | |
| 0.236 | 0.004 | 0.236 | NMDA receptor agonist | 0.168 0.006 CID_46780317 0.112 0.015 CID_154699645 | ||
| 0.248 | 0.021 | 0.248 | NADPH oxidase inhibitor | 0.169 0.045 CID_46780317 0.109 0.097 CID_154699645 | ||
| 0.243 | 0.017 | 0.243 | Toll-Like receptor antagonist | 0.225 0.022 CID_46780317 | ||
| 0.232 | 0.009 | 0.25 | CF transmembrane conductance regulator agonist | 0.25 0.006 CID_46780317 0.167 0.05 CID_154699645 | CID_46780317 | |
| 0.264 | 0.044 | 0.348 | Anesthetic general | 0.348 0.024 CID_46780317 | CID_46780317 | |
| 0.299 | 0.08 | 0.428 | 12-Lipoxygenase inhibitor | 0.428 0.033 CID_46780317 0.181 0.172 CID_154699645 | CID_46780317 | |
| 0.224 | 0.008 | 0.224 | NMDA 2 receptor antagonist | 0.133 0.02 CID_46780317 | ||
| 0.348 | 0.131 | 0.349 | Transcription factor inhibitor | 0.349 0.13 CID_46780317 0.287 0.162 CID_154699645 | CID_46780317 | |
| 0.224 | 0.008 | 0.224 | HIV-1 integrase (Overall Integration) inhibitor | 0.209 0.01 CID_46780317 | ||
| 0.231 | 0.019 | 0.231 | Glutamate receptor antagonist | 0.139 0.058 CID_46780317 | ||
| 0.246 | 0.035 | 0.246 | Lipocortins synthesis antagonist | |||
| 0.251 | 0.042 | 0.251 | Glyceraldehyde-3-phosphate dehydrogenase inhibitor | 0.225 0.055 CID_46780317 | ||
| 0.207 | 0.003 | 0.207 | NMDA receptor glycine site agonist | 0.16 0.004 CID_46780317 0.131 0.006 CID_154699645 | ||
| 0.229 | 0.025 | 0.229 | Toll-Like receptor 9 antagonist | 0.12 0.085 CID_46780317 | ||
| 0.235 | 0.033 | 0.235 | Histone acetyltransferase inhibitor | 0.199 0.07 CID_46780317 | ||
| 0.265 | 0.068 | 0.265 | Interleukin agonist | 0.166 0.153 CID_46780317 | ||
| 0.209 | 0.013 | 0.209 | NMDA receptor antagonist | 0.202 0.014 CID_46780317 | ||
| 0.206 | 0.01 | 0.206 | Triose-phosphate isomerase inhibitor | 0.168 0.016 CID_46780317 0.137 0.024 CID_154699645 | ||
| 0.316 | 0.124 | 0.366 | Antibacterial | 0.366 0.093 CID_46780317 | CID_46780317 | |
| 0.2 | 0.01 | 0.24 | Creatine kinase inhibitor | 0.24 0.006 CID_46780317 0.144 0.026 CID_154699645 | CID_46780317 | |
| 0.223 | 0.034 | 0.223 | Succinate dehydrogenase inhibitor | 0.218 0.037 CID_46780317 0.172 0.077 CID_154699645 | ||
| 0.226 | 0.038 | 0.226 | 3C-like protease (Human coronavirus) inhibitor | 0.146 0.108 CID_46780317 | ||
| 0.294 | 0.106 | 0.328 | Thioredoxin glutathione reductase inhibitor | 0.325 0.088 CID_46780317 0.328 0.087 CID_154699645 | CID_154699645 | |
| 0.234 | 0.047 | 0.234 | LIM domain kinase 1 inhibitor | 0.206 0.06 CID_46780317 | ||
| 0.191 | 0.005 | 0.191 | NMDA 2C receptor antagonist | 0.116 0.011 CID_46780317 0.057 0.05 CID_154699645 | ||
| 0.227 | 0.042 | 0.227 | Amyloid beta precursor protein antagonist | 0.142 0.111 CID_46780317 | ||
| 0.24 | 0.056 | 0.241 | RNA-directed DNA polymerase inhibitor | 0.241 0.055 CID_46780317 | CID_46780317 | |
| 0.273 | 0.09 | 0.343 | Streptokinase A inhibitor | 0.343 0.064 CID_46780317 | CID_46780317 | |
| 0.18 | 0.001 | 0.18 | Glutamate (mGluR8) agonist | 0.135 0.002 CID_46780317 0.077 0.004 CID_154699645 | ||
| 0.287 | 0.108 | 0.349 | Prostaglandin dehydrogenase inhibitor | 0.349 0.083 CID_46780317 | CID_46780317 | |
| 0.199 | 0.023 | 0.199 | Cathepsin H inhibitor | 0.144 0.051 CID_46780317 0.108 0.092 CID_154699645 | ||
| 0.187 | 0.014 | 0.292 | Histidine decarboxylase inhibitor | 0.292 0.007 CID_46780317 | CID_46780317 | |
| 0.225 | 0.052 | 0.225 | I kappa B kinase epsilon inhibitor | 0.15 0.119 CID_46780317 | ||
| 0.177 | 0.007 | 0.177 | Biliverdin reductase inhibitor | 0.126 0.013 CID_46780317 0.079 0.027 CID_154699645 | ||
| 0.227 | 0.058 | 0.227 | Dual specificity tyrosine-phosphorylation regulated kinase 3 inhibitor | |||
| 0.185 | 0.018 | 0.185 | UDP-N-acetylglucosamine 1-carboxyvinyltransferase inhibitor | 0.145 0.028 CID_46780317 0.105 0.049 CID_154699645 | ||
| 0.168 | 0.006 | 0.168 | Androgen agonist | 0.14 0.008 CID_46780317 0.107 0.013 CID_154699645 | ||
| 0.172 | 0.013 | 0.172 | Bcr-Abl kinase inhibitor | 0.106 0.035 CID_46780317 0.099 0.042 CID_154699645 | ||
| 0.161 | 0.004 | 0.161 | Glutamate (mGluR group III) agonist | 0.155 0.005 CID_46780317 | ||
| 0.217 | 0.061 | 0.217 | Neurotrophic factor enhancer | 0.187 0.09 CID_46780317 | ||
| 0.165 | 0.017 | 0.174 | Urease inhibitor | 0.174 0.014 CID_46780317 0.144 0.026 CID_154699645 | CID_46780317 | |
| 0.195 | 0.052 | 0.337 | Heat shock protein 90 alpha antagonist | 0.337 0.01 CID_46780317 0.18 0.062 CID_154699645 | CID_46780317 | |
| 0.158 | 0.018 | 0.183 | DOPA decarboxylase inhibitor | 0.183 0.01 CID_46780317 0.102 0.071 CID_154699645 | CID_46780317 | |
| 0.159 | 0.018 | 0.159 | Phosphodiesterase 7B inhibitor | |||
| 0.159 | 0.019 | 0.159 | Nitric-oxide synthase inhibitor | 0.089 0.08 CID_46780317 | ||
| 0.223 | 0.085 | 0.223 | Neuropeptide Y2 antagonist | |||
| 0.158 | 0.021 | 0.158 | CDK3/cyclin E inhibitor | 0.124 0.051 CID_46780317 0.103 0.081 CID_154699645 | ||
| 0.156 | 0.019 | 0.183 | Porphobilinogen synthase inhibitor | 0.183 0.014 CID_46780317 0.069 0.056 CID_154699645 | CID_46780317 | |
| 0.142 | 0.011 | 0.142 | Thioredoxin reductase inhibitor | 0.1 0.028 CID_46780317 0.097 0.031 CID_154699645 | ||
| 0.135 | 0.004 | 0.135 | AMPA 1 receptor antagonist | 0.058 0.009 CID_46780317 0.033 0.018 CID_154699645 | ||
| 0.168 | 0.038 | 0.168 | Alkylator | 0.164 0.04 CID_46780317 | ||
| 0.141 | 0.011 | 0.154 | Alcohol oxidase inhibitor | 0.154 0.01 CID_46780317 0.053 0.041 CID_154699645 | CID_46780317 | |
| 0.139 | 0.008 | 0.139 | Purinergic P2X1 antagonist | 0.127 0.01 CID_46780317 0.058 0.047 CID_154699645 | ||
| 0.175 | 0.045 | 0.184 | Alkaline phosphatase inhibitor | 0.184 0.04 CID_46780317 | CID_46780317 | |
| 0.207 | 0.078 | 0.214 | MAP kinase kinase 2 inhibitor | 0.214 0.073 CID_46780317 | CID_46780317 | |
| 0.189 | 0.062 | 0.418 | Peroxidase inhibitor | 0.418 0.018 CID_46780317 | CID_46780317 | |
| 0.143 | 0.017 | 0.143 | Toll-Like receptor 3 antagonist | |||
| 0.135 | 0.011 | 0.135 | GABA aminotransferase inhibitor | 0.1 0.027 CID_46780317 | ||
| 0.293 | 0.169 | 0.341 | DNA polymerase beta inhibitor | 0.341 0.144 CID_46780317 | CID_46780317 | |
| 0.154 | 0.031 | 0.168 | Interleukin 8 antagonist | 0.168 0.024 CID_46780317 | CID_46780317 | |
| 0.186 | 0.063 | 0.228 | Mcl-1 antagonist | 0.228 0.044 CID_46780317 | CID_46780317 | |
| 0.154 | 0.032 | 0.154 | GABA C receptor agonist | 0.148 0.035 CID_46780317 | ||
| 0.179 | 0.058 | 0.179 | Polo-like kinase-3 inhibitor | |||
| 0.162 | 0.043 | 0.163 | Sphingosine 1-phosphate receptor 5 antagonist | 0.163 0.042 CID_46780317 | CID_46780317 | |
| 0.18 | 0.061 | 0.22 | Phospholipase C inhibitor | 0.22 0.033 CID_46780317 | CID_46780317 | |
| 0.126 | 0.008 | 0.126 | NMDA receptor subunit 3B antagonist | 0.103 0.01 CID_46780317 0.042 0.033 CID_154699645 | ||
| 0.167 | 0.05 | 0.167 | Cell wall synthesis inhibitor | 0.155 0.061 CID_46780317 | ||
| 0.192 | 0.076 | 0.192 | Focal adhesion kinase 2 inhibitor | |||
| 0.148 | 0.031 | 0.148 | Carbonic anhydrase XV inhibitor | 0.102 0.065 CID_46780317 | ||
| 0.119 | 0.004 | 0.119 | NMDA receptor glycine site antagonist | 0.099 0.004 CID_46780317 0.034 0.01 CID_154699645 | ||
| 0.119 | 0.004 | 0.249 | Sodium/calcium exchanger inhibitor | 0.249 0.003 CID_46780317 | CID_46780317 | |
| 0.145 | 0.031 | 0.145 | Carbonic anhydrase III inhibitor | 0.118 0.046 CID_46780317 | ||
| 0.125 | 0.011 | 0.125 | D-Ala-D-Ala ligase inhibitor | 0.124 0.012 CID_46780317 | ||
| 0.22 | 0.106 | 0.22 | 5 Hydroxytryptamine release stimulant | 0.186 0.135 CID_46780317 | ||
| 0.118 | 0.005 | 0.118 | Glutamate (mGluR4) antagonist | 0.082 0.008 CID_46780317 0.06 0.014 CID_154699645 | ||
| 0.243 | 0.13 | 0.243 | Cholesterol antagonist | 0.231 0.139 CID_46780317 0.202 0.163 CID_154699645 | ||
| 0.117 | 0.005 | 0.117 | Exportin-1 inhibitor | 0.081 0.024 CID_46780317 0.083 0.022 CID_154699645 | ||
| 0.116 | 0.004 | 0.116 | Glutamate (mGluR4) agonist | 0.103 0.004 CID_46780317 0.031 0.029 CID_154699645 | ||
| 0.116 | 0.004 | 0.116 | Transcription factor RelA inhibitor | 0.109 0.005 CID_46780317 0.084 0.014 CID_154699645 | ||
| 0.281 | 0.169 | 0.477 | Alpha-glucosidase inhibitor | 0.477 0.087 CID_46780317 | CID_46780317 | |
| 0.137 | 0.026 | 0.137 | Anabolic | 0.133 0.029 CID_46780317 0.112 0.048 CID_154699645 | ||
| 0.126 | 0.015 | 0.126 | Sphingosine 1-phosphate receptor 4 agonist | 0.095 0.027 CID_46780317 0.074 0.041 CID_154699645 | ||
| 0.132 | 0.022 | 0.132 | Potassium channel (Voltage-sensitive) activator | |||
| 0.114 | 0.004 | 0.114 | Dihydroorotate oxidase inhibitor | 0.088 0.007 CID_46780317 0.068 0.019 CID_154699645 | ||
| 0.168 | 0.058 | 0.168 | Protein kinase (CK1) gamma inhibitor | |||
| 0.15 | 0.043 | 0.15 | Ca2+-transporting ATPase inhibitor | 0.15 0.042 CID_46780317 0.137 0.084 CID_154699645 | ||
| 0.279 | 0.173 | 0.349 | DNA directed DNA polymerase inhibitor | 0.349 0.139 CID_46780317 | CID_46780317 | |
| 0.162 | 0.059 | 0.162 | Thiol protease inhibitor | 0.124 0.108 CID_46780317 | ||
| 0.211 | 0.107 | 0.211 | DNA synthesis inhibitor | 0.186 0.145 CID_46780317 | ||
| 0.153 | 0.05 | 0.357 | M18 aspartyl aminopeptidase inhibitor | 0.357 0.007 CID_46780317 | CID_46780317 | |
| 0.126 | 0.024 | 0.128 | Phosphofructokinase-1 inhibitor | 0.128 0.023 CID_46780317 0.065 0.052 CID_154699645 | CID_46780317 | |
| 0.102 | 0.003 | 0.102 | Nerve growth factor antagonist | 0.075 0.005 CID_46780317 0.067 0.006 CID_154699645 | ||
| 0.163 | 0.066 | 0.163 | Cytidine deaminase inhibitor | |||
| 0.101 | 0.005 | 0.14 | Catechol O-methyltransferase inhibitor | 0.14 0.004 CID_46780317 0.064 0.006 CID_154699645 | CID_46780317 | |
| 0.13 | 0.035 | 0.146 | Toll-Like receptor 4 antagonist | 0.146 0.023 CID_46780317 | CID_46780317 | |
| 0.135 | 0.04 | 0.135 | GABA C receptor antagonist | 0.118 0.054 CID_46780317 | ||
| 0.138 | 0.043 | 0.138 | Aminopeptidase B inhibitor | 0.121 0.052 CID_46780317 0.089 0.073 CID_154699645 | ||
| 0.184 | 0.09 | 0.184 | Ca2+/calmodulin-dependent kinase II beta inhibitor | |||
| 0.107 | 0.014 | 0.107 | Glutamate (mGluR1) antagonist | 0.052 0.046 CID_154699645 | ||
| 0.102 | 0.01 | 0.116 | Enoyl-[acyl-carrier-protein] reductase inhibitor | 0.116 0.007 CID_46780317 | CID_46780317 | |
| 0.122 | 0.029 | 0.122 | Thioredoxin inhibitor | 0.09 0.062 CID_46780317 | ||
| 0.104 | 0.012 | 0.104 | NMDA 2A receptor antagonist | 0.074 0.022 CID_46780317 | ||
| 0.116 | 0.025 | 0.116 | Glutamate release inhibitor | 0.085 0.073 CID_46780317 | ||
| 0.119 | 0.03 | 0.153 | Interleukin 12 antagonist | 0.153 0.012 CID_46780317 | CID_46780317 | |
| 0.107 | 0.018 | 0.107 | Argininosuccinate synthase inhibitor | 0.092 0.021 CID_46780317 | ||
| 0.099 | 0.01 | 0.099 | Plasminogen activator inhibitor antagonist | 0.077 0.016 CID_46780317 0.05 0.033 CID_154699645 | ||
| 0.157 | 0.071 | 0.157 | Hexokinase inhibitor | 0.137 0.095 CID_46780317 | ||
| 0.135 | 0.049 | 0.135 | Sphingosine 1-phosphate receptor 4 antagonist | 0.114 0.085 CID_46780317 0.108 0.099 CID_154699645 | ||
| 0.092 | 0.007 | 0.092 | Estrogen-related receptor alpha antagonist | 0.064 0.01 CID_46780317 0.03 0.025 CID_154699645 | ||
| 0.119 | 0.035 | 0.141 | Alcohol dehydrogenase inhibitor | 0.141 0.023 CID_46780317 | CID_46780317 | |
| 0.137 | 0.054 | 0.137 | Protein kinase (CK1) gamma 2 inhibitor | |||
| 0.133 | 0.05 | 0.133 | DNA repair enzyme inhibitor | 0.122 0.068 CID_46780317 | ||
| 0.114 | 0.032 | 0.114 | Carbonic anhydrase VI inhibitor | 0.082 0.054 CID_46780317 | ||
| 0.089 | 0.006 | 0.089 | Glutamate (mGluR group III) antagonist | 0.061 0.012 CID_46780317 0.049 0.022 CID_154699645 | ||
| 0.16 | 0.079 | 0.16 | Sigma receptor agonist | |||
| 0.111 | 0.029 | 0.111 | Inducible nitric-oxide synthase inhibitor | |||
| 0.108 | 0.027 | 0.108 | Glutamate dehydrogenase inhibitor | 0.105 0.028 CID_46780317 0.066 0.063 CID_154699645 | ||
| 0.196 | 0.117 | 0.196 | Calpain inhibitor | 0.184 0.129 CID_46780317 | ||
| 0.093 | 0.014 | 0.093 | Glycine transporter 2 inhibitor | 0.073 0.02 CID_46780317 | ||
| 0.09 | 0.012 | 0.09 | Potassium channel intermediate-conductance Ca-activated blocker | 0.055 0.052 CID_46780317 0.066 0.032 CID_154699645 | ||
| 0.114 | 0.036 | 0.114 | Lanosterol 14 alpha demethylase inhibitor | |||
| 0.205 | 0.127 | 0.222 | Tyrosine 3 hydroxylase inhibitor | 0.222 0.1 CID_46780317 | CID_46780317 | |
| 0.168 | 0.09 | 0.179 | MAP kinase kinase 5 inhibitor | 0.179 0.065 CID_46780317 | CID_46780317 | |
| 0.185 | 0.107 | 0.185 | Dyrk kinase inhibitor | 0.161 0.126 CID_46780317 | ||
| 0.083 | 0.006 | 0.083 | Dihydropteroate synthase inhibitor | 0.058 0.012 CID_46780317 | ||
| 0.134 | 0.057 | 0.148 | Anesthetic local | 0.148 0.05 CID_46780317 | CID_46780317 | |
| 0.142 | 0.066 | 0.142 | Calcium channel blocker | |||
| 0.086 | 0.01 | 0.086 | NMDA receptor subunit 3A antagonist | 0.07 0.014 CID_46780317 | ||
| 0.082 | 0.007 | 0.082 | Thymidylate synthase inhibitor | 0.061 0.016 CID_46780317 | ||
| 0.081 | 0.007 | 0.081 | Fructose-1,6-bisphosphatase inhibitor | 0.061 0.017 CID_46780317 | ||
| 0.116 | 0.043 | 0.117 | Breast cancer-resistant protein inhibitor | 0.117 0.042 CID_46780317 | CID_46780317 | |
| 0.121 | 0.048 | 0.121 | AMP-activated protein kinase stimulant | 0.113 0.055 CID_46780317 | ||
| 0.092 | 0.02 | 0.092 | S-adenosyl-L-methionine decarboxylase inhibitor | 0.071 0.056 CID_46780317 | ||
| 0.079 | 0.008 | 0.079 | Potassium channel (Inward rectifier) activator | 0.056 0.026 CID_46780317 0.062 0.017 CID_154699645 | ||
| 0.102 | 0.032 | 0.102 | Myeloperoxidase inhibitor | 0.085 0.057 CID_46780317 | ||
| 0.112 | 0.043 | 0.112 | MAP kinase kinase 1 inhibitor | |||
| 0.123 | 0.054 | 0.123 | Transcription factor STAT6 inhibitor | |||
| 0.076 | 0.008 | 0.076 | Potassium channel (ATP-sensitive) activator | 0.053 0.025 CID_46780317 0.059 0.017 CID_154699645 | ||
| 0.157 | 0.09 | 0.157 | Catenin beta inhibitor | |||
| 0.096 | 0.029 | 0.096 | T cell inhibitor | |||
| 0.199 | 0.133 | 0.199 | 5 Hydroxytryptamine 1E antagonist | 0.198 0.133 CID_46780317 | ||
| 0.126 | 0.061 | 0.126 | Beta amyloid protein antagonist | 0.123 0.065 CID_46780317 | ||
| 0.095 | 0.03 | 0.095 | Prostaglandin-E synthase inhibitor | |||
| 0.101 | 0.036 | 0.101 | Glutathione S-transferase inhibitor | 0.08 0.061 CID_46780317 0.078 0.064 CID_154699645 | ||
| 0.128 | 0.063 | 0.159 | Aldehyde dehydrogenase inhibitor | 0.159 0.042 CID_46780317 | CID_46780317 | |
| 0.118 | 0.055 | 0.118 | Ferrochelatase inhibitor | |||
| 0.068 | 0.005 | 0.083 | 3-Hydroxyanthranilate 3,4-dioxygenase inhibitor | 0.083 0.004 CID_46780317 0.043 0.025 CID_154699645 | CID_46780317 | |
| 0.078 | 0.017 | 0.078 | Calcium channel P-type blocker | 0.062 0.05 CID_46780317 0.063 0.046 CID_154699645 | ||
| 0.089 | 0.028 | 0.089 | GABA B receptor agonist | 0.088 0.029 CID_46780317 | ||
| 0.131 | 0.071 | 0.135 | Sphingosine 1-phosphate receptor 2 antagonist | 0.135 0.065 CID_46780317 | CID_46780317 | |
| 0.074 | 0.014 | 0.074 | CD45 antagonist | 0.056 0.025 CID_46780317 | ||
| 0.13 | 0.071 | 0.315 | Interleukin 4 antagonist | 0.315 0.008 CID_46780317 | CID_46780317 | |
| 0.069 | 0.01 | 0.069 | AICAR transformylase inhibitor | 0.048 0.024 CID_46780317 | ||
| 0.097 | 0.039 | 0.181 | NAD(P)H dehydrogenase (quinone) inhibitor | 0.181 0.012 CID_46780317 | CID_46780317 | |
| 0.065 | 0.009 | 0.065 | AMPA 4 receptor antagonist | 0.042 0.023 CID_46780317 | ||
| 0.066 | 0.01 | 0.066 | Kainate receptor 2 antagonist | |||
| 0.094 | 0.038 | 0.094 | Phosphodiesterase 3A inhibitor | |||
| 0.091 | 0.035 | 0.105 | Glutamate decarboxylase inhibitor | 0.105 0.027 CID_46780317 | CID_46780317 | |
| 0.109 | 0.053 | 0.109 | Cyclin-dependent kinase 9 inhibitor | |||
| 0.117 | 0.061 | 0.117 | Photosensitizer | 0.116 0.063 CID_46780317 | ||
| 0.071 | 0.016 | 0.071 | Ryanodine receptor antagonist | 0.063 0.029 CID_46780317 | ||
| 0.078 | 0.024 | 0.116 | Nitric oxide donor | 0.058 0.053 CID_46780317 0.116 0.004 CID_154699645 | CID_154699645 | |
| 0.062 | 0.008 | 0.062 | Potassium channel Kv1.1 blocker | 0.039 0.025 CID_46780317 | ||
| 0.094 | 0.041 | 0.094 | Carbonic anhydrase XIII inhibitor | |||
| 0.07 | 0.018 | 0.07 | Epithelial sodium channel blocker | |||
| 0.136 | 0.084 | 0.136 | Pregnane X receptor agonist | |||
| 0.082 | 0.03 | 0.082 | Bcl2 antagonist | |||
| 0.08 | 0.028 | 0.08 | Aromatase inhibitor | 0.072 0.033 CID_46780317 | ||
| 0.137 | 0.086 | 0.137 | Neuropeptide Y1 antagonist | |||
| 0.078 | 0.027 | 0.078 | Phosphodiesterase VII inhibitor | |||
| 0.077 | 0.026 | 0.077 | Maillard reaction inhibitor | 0.061 0.034 CID_46780317 | ||
| 0.208 | 0.158 | 0.298 | Caspase 3 stimulant | 0.298 0.079 CID_46780317 | CID_46780317 | |
| 0.073 | 0.024 | 0.093 | Potassium channel (Ca-activated) blocker | 0.093 0.011 CID_154699645 | CID_154699645 | |
| 0.098 | 0.049 | 0.098 | Calcium antagonist | 0.08 0.064 CID_154699645 | ||
| 0.056 | 0.007 | 0.056 | AMPA 3 receptor antagonist | 0.029 0.021 CID_46780317 | ||
| 0.102 | 0.054 | 0.102 | Electrolyte absorption antagonist | |||
| 0.09 | 0.043 | 0.09 | Catalase inhibitor | |||
| 0.096 | 0.051 | 0.096 | Polo-like kinase-1 inhibitor | |||
| 0.161 | 0.116 | 0.161 | Anticonvulsant | |||
| 0.07 | 0.026 | 0.07 | Ornithine carbamoyltransferase inhibitor | 0.057 0.034 CID_46780317 | ||
| 0.259 | 0.215 | 0.259 | 5 Hydroxytryptamine release inhibitor | 0.246 0.233 CID_46780317 | ||
| 0.08 | 0.036 | 0.08 | Carbonic anhydrase VA inhibitor | |||
| 0.049 | 0.005 | 0.049 | Kainate receptor 5 antagonist | 0.026 0.011 CID_46780317 0.032 0.009 CID_154699645 | ||
| 0.046 | 0.002 | 0.064 | Glutamate (mGluR6) agonist | 0.064 0.002 CID_46780317 0.015 0.006 CID_154699645 | CID_46780317 | |
| 0.089 | 0.046 | 0.089 | Glutamate receptor agonist | |||
| 0.062 | 0.019 | 0.062 | Phosphodiesterase 7A inhibitor | |||
| 0.057 | 0.014 | 0.057 | Kinesin antagonist | |||
| 0.057 | 0.014 | 0.057 | Kinesin-like protein 1 inhibitor | |||
| 0.134 | 0.092 | 0.264 | Heat shock protein 90 antagonist | 0.264 0.017 CID_46780317 | CID_46780317 | |
| 0.045 | 0.003 | 0.045 | Progesterone receptor B antagonist | 0.035 0.004 CID_46780317 0.039 0.004 CID_154699645 | ||
| 0.093 | 0.052 | 0.093 | NADH dehydrogenase inhibitor | 0.089 0.058 CID_46780317 | ||
| 0.056 | 0.017 | 0.056 | CDK5/p25 inhibitor | 0.039 0.031 CID_46780317 | ||
| 0.043 | 0.004 | 0.043 | Fructose-1,6-bisphosphatase 1 inhibitor | 0.033 0.006 CID_46780317 | ||
| 0.045 | 0.006 | 0.045 | Kainate receptor 1 antagonist | 0.024 0.013 CID_46780317 0.019 0.016 CID_154699645 | ||
| 0.047 | 0.008 | 0.047 | Kainate receptor 4 antagonist | 0.027 0.015 CID_46780317 0.036 0.011 CID_154699645 | ||
| 0.118 | 0.079 | 0.118 | Alpha-N-acetylglucosaminidase inhibitor | 0.104 0.096 CID_46780317 | ||
| 0.054 | 0.016 | 0.054 | GABA B receptor antagonist | 0.041 0.034 CID_46780317 | ||
| 0.063 | 0.026 | 0.063 | Dihydroorotate dehydrogenase inhibitor | 0.052 0.035 CID_46780317 | ||
| 0.109 | 0.072 | 0.109 | Calcium channel (voltage-sensitive) blocker | |||
| 0.093 | 0.057 | 0.093 | Falcipain 2 inhibitor | |||
| 0.065 | 0.03 | 0.066 | Botulinum neurotoxin type A inhibitor | 0.066 0.03 CID_46780317 | CID_46780317 | |
| 0.122 | 0.087 | 0.122 | Cytokine production inhibitor | |||
| 0.094 | 0.059 | 0.094 | Falcipain inhibitor | |||
| 0.111 | 0.077 | 0.111 | Calcium channel N-type blocker | |||
| 0.047 | 0.014 | 0.047 | Integrin alpha2 antagonist | |||
| 0.133 | 0.099 | 0.133 | Cyclin-dependent kinase 8 inhibitor | |||
| 0.098 | 0.065 | 0.098 | GABA C receptor rho-1 antagonist | |||
| 0.138 | 0.105 | 0.138 | Interleukin-1 receptor-associated protein kinase 1 inhibitor | |||
| 0.134 | 0.102 | 0.134 | Heat shock protein 70 antagonist | |||
| 0.118 | 0.086 | 0.118 | Papain-like protease (SARS coronavirus) inhibitor | |||
| 0.072 | 0.041 | 0.072 | Carbonic anhydrase V inhibitor | |||
| 0.085 | 0.054 | 0.085 | TIE antagonist | |||
| 0.039 | 0.008 | 0.039 | LFA antagonist | |||
| 0.072 | 0.042 | 0.072 | Vanilloid 1 antagonist | |||
| 0.04 | 0.01 | 0.04 | NMDA 2D receptor antagonist | 0.029 0.016 CID_46780317 | ||
| 0.065 | 0.035 | 0.065 | Carbonic anhydrase IX inhibitor | 0.047 0.045 CID_46780317 | ||
| 0.042 | 0.013 | 0.042 | AMPA 2 receptor antagonist | |||
| 0.041 | 0.013 | 0.041 | Endothelial nitric-oxide synthase inhibitor | |||
| 0.036 | 0.008 | 0.036 | Estrogen-related receptor gamma antagonist | 0.033 0.011 CID_46780317 0.027 0.025 CID_154699645 | ||
| 0.082 | 0.055 | 0.082 | TIE-2 antagonist | |||
| 0.055 | 0.028 | 0.055 | Lysophosphatidic acid 3 receptor antagonist | |||
| 0.046 | 0.019 | 0.046 | Potassium channel KCNQ activator | |||
| 0.046 | 0.019 | 0.046 | Delayed rectifier potassium channel activator | |||
| 0.063 | 0.036 | 0.079 | 3-Oxoacyl-[acyl-carrier-protein] synthase inhibitor | 0.079 0.025 CID_46780317 | CID_46780317 | |
| 0.06 | 0.033 | 0.06 | CC chemokine 2 receptor antagonist | |||
| 0.045 | 0.019 | 0.045 | TRPM8 blocker | |||
| 0.142 | 0.116 | 0.142 | ATPase inhibitor | |||
| 0.13 | 0.105 | 0.13 | GABA C receptor rho-2 antagonist | |||
| 0.073 | 0.048 | 0.073 | Calcium channel L-type blocker | |||
| 0.047 | 0.022 | 0.047 | Dihydrofolate reductase inhibitor | |||
| 0.068 | 0.043 | 0.068 | MDM2 inhibitor | |||
| 0.029 | 0.005 | 0.029 | Factor XIII inhibitor | |||
| 0.06 | 0.035 | 0.06 | Carbonic anhydrase VB inhibitor | |||
| 0.117 | 0.094 | 0.324 | Interleukin 1 antagonist | 0.324 0.009 CID_154699645 | CID_154699645 | |
| 0.12 | 0.098 | 0.12 | Protein kinase (CK1) gamma 1 inhibitor | |||
| 0.035 | 0.013 | 0.035 | CDK4/cyclin D3 inhibitor | |||
| 0.143 | 0.121 | 0.143 | Neurotensin receptor agonist | 0.142 0.122 CID_46780317 | ||
| 0.158 | 0.137 | 0.255 | Antiamyloidogenic | 0.255 0.069 CID_46780317 | CID_46780317 | |
| 0.045 | 0.024 | 0.045 | Heme oxygenase inhibitor | |||
| 0.051 | 0.03 | 0.051 | Collagenase inhibitor | 0.047 0.038 CID_154699645 | ||
| 0.033 | 0.013 | 0.033 | Kynurenine 3 monooxygenase inhibitor | |||
| 0.034 | 0.015 | 0.034 | Hypoxanthine phosphoribosyltransferase inhibitor | |||
| 0.027 | 0.009 | 0.027 | ICAM 1 antagonist | |||
| 0.042 | 0.023 | 0.042 | Vascular adhesion protein 1 inhibitor | |||
| 0.102 | 0.084 | 0.102 | Acetylcholine release stimulant | |||
| 0.062 | 0.045 | 0.062 | Carbonic anhydrase inhibitor | |||
| 0.053 | 0.036 | 0.053 | Carbonic anhydrase XII inhibitor | 0.046 0.041 CID_46780317 | ||
| 0.209 | 0.192 | 0.402 | Histamine release inhibitor | 0.402 0.075 CID_46780317 | CID_46780317 | |
| 0.029 | 0.013 | 0.029 | Integrin alpha2beta1 antagonist | |||
| 0.046 | 0.03 | 0.046 | Potassium channel small-conductance Ca-activated blocker | |||
| 0.023 | 0.007 | 0.023 | Kainate receptor 3 antagonist | 0.017 0.013 CID_154699645 | ||
| 0.021 | 0.005 | 0.021 | CDK2/cyclin A3 inhibitor | |||
| 0.041 | 0.026 | 0.041 | Phenylethanolamine N methyltransferase inhibitor | |||
| 0.134 | 0.121 | 0.134 | Tumour necrosis factor antagonist | |||
| 0.141 | 0.128 | 0.141 | Non-steroidal antiinflammatory agent | |||
| 0.048 | 0.035 | 0.048 | Carbonic anhydrase XIV inhibitor | |||
| 0.124 | 0.11 | 0.16 | Phospholipase A2 inhibitor | 0.16 0.065 CID_46780317 | CID_46780317 | |
| 0.079 | 0.066 | 0.079 | Histamine H2 receptor antagonist | |||
| 0.155 | 0.143 | 0.155 | Cyclic AMP phosphodiesterase inhibitor | |||
| 0.045 | 0.033 | 0.045 | Adenylate cyclase 1 inhibitor | |||
| 0.026 | 0.015 | 0.026 | Complement factor 1s inhibitor | |||
| 0.026 | 0.014 | 0.026 | Glutamate (mGluR1) agonist | |||
| 0.04 | 0.031 | 0.04 | Kainate receptor agonist | |||
| 0.052 | 0.042 | 0.052 | Lysine-specific demethylase 1A inhibitor | |||
| 0.038 | 0.028 | 0.038 | Urate transporter 1 inhibitor | 0.036 0.03 CID_46780317 | ||
| 0.043 | 0.034 | 0.056 | Phosphorylase inhibitor | 0.056 0.027 CID_46780317 | CID_46780317 | |
| 0.026 | 0.017 | 0.026 | Complement factor 1r inhibitor | |||
| 0.015 | 0.006 | 0.015 | Integrin beta2 antagonist | |||
| 0.015 | 0.006 | 0.015 | Human herpes virus 5 capsid protein P40 inhibitor | 0.015 0.006 CID_154699645 | ||
| 0.082 | 0.073 | 0.082 | Pim-3 kinase inhibitor | |||
| 0.164 | 0.157 | 0.164 | 5 Hydroxytryptamine 3E antagonist | |||
| 0.033 | 0.026 | 0.033 | Retinoid X alpha receptor agonist | |||
| 0.142 | 0.135 | 0.142 | Death-associated protein kinase 3 inhibitor | |||
| 0.065 | 0.059 | 0.065 | Secretase beta inhibitor | |||
| 0.05 | 0.044 | 0.05 | Carbonic anhydrase II inhibitor | |||
| 0.126 | 0.119 | 0.126 | Protein kinase (CK1) gamma 3 inhibitor | |||
| 0.125 | 0.119 | 0.128 | Arachidonic acid antagonist | 0.128 0.115 CID_46780317 | CID_46780317 | |
| 0.054 | 0.048 | 0.054 | Sphingosine 1-phosphate receptor 3 antagonist | |||
| 0.039 | 0.034 | 0.039 | Carbonic anhydrase IV inhibitor | |||
| 0.033 | 0.03 | 0.033 | Adenosine uptake inhibitor | |||
| 0.099 | 0.097 | 0.099 | Amylase inhibitor | |||
| 0.083 | 0.081 | 0.083 | ABCA1 expression enhancer | |||
| 0.053 | 0.051 | 0.053 | Carbamoyl phosphate synthetase inhibitor | |||
| 0.016 | 0.015 | 0.016 | Sodium/hydrogen exchanger inhibitor | |||
| 0.09 | 0.088 | 0.096 | Beta glucuronidase inhibitor | 0.096 0.076 CID_46780317 | CID_46780317 | |
| 0.159 | 0.158 | 0.159 | ErbB-1 antagonist | |||
| 0.077 | 0.08 | 0.09 | Estrogen-related receptor beta agonist | 0.09 0.04 CID_46780317 | CID_46780317 | |
| 0.09 | 0.094 | 0.399 | Interleukin 1b antagonist | 0.399 0.005 CID_154699645 | CID_154699645 | |
| 0.12 | 0.129 | 0.179 | Dual specificity phosphatase 3 inhibitor | 0.179 0.074 CID_46780317 | CID_46780317 | |
| 0.104 | 0.114 | 0.15 | Protein kinase stimulant | 0.15 0.069 CID_46780317 | CID_46780317 | |
| 0.096 | 0.105 | 0.137 | Cyclooxygenase 1 inhibitor | 0.137 0.065 CID_154699645 | CID_154699645 | |
| 0.042 | 0.053 | 0.161 | Alpha tubulin antagonist | 0.161 0.008 CID_46780317 | CID_46780317 | |
| 0.167 | 0.184 | 0.211 | Transcription factor STAT3 inhibitor | 0.211 0.12 CID_46780317 | CID_46780317 | |
| 0.17 | 0.188 | 0.207 | Transcription factor STAT inhibitor | 0.207 0.128 CID_46780317 | CID_46780317 | |
| 0.073 | 0.096 | 0.11 | Monophenol monooxygenase inhibitor | 0.11 0.068 CID_46780317 | CID_46780317 | |
| 0.038 | 0.061 | 0.08 | Xanthine dehydrogenase inhibitor | 0.08 0.024 CID_46780317 | CID_46780317 | |
| 0.003 | 0.026 | 0.008 | Insulin like growth factor 3 antagonist | 0.008 0.003 CID_46780317 | CID_46780317 | |
| 0.119 | 0.146 | 0.151 | DNA methyltransferase I inhibitor | 0.151 0.103 CID_46780317 | CID_46780317 | |
| 0.076 | 0.104 | 0.093 | Xanthine oxidase inhibitor | 0.093 0.068 CID_46780317 | CID_46780317 | |
| 0.049 | 0.095 | 0.058 | Heme oxygenase stimulant | 0.058 0.051 CID_46780317 | CID_46780317 | |
| 0.11 | 0.162 | 0.161 | Pyruvate kinase inhibitor | 0.161 0.106 CID_46780317 | CID_46780317 | |
| 0.099 | 0.153 | 0.12 | Vanilloid 1 agonist | 0.12 0.088 CID_46780317 | CID_46780317 | |
| 0.051 | 0.106 | 0.061 | Beta 2 adrenoreceptor agonist | 0.061 0.044 CID_46780317 | CID_46780317 | |
| 0.064 | 0.14 | 0.112 | Cystathionine beta-synthase inhibitor | 0.112 0.064 CID_46780317 | CID_46780317 | |
| 0.06 | 0.148 | 0.135 | Interleukin 5 antagonist | 0.135 0.016 CID_46780317 | CID_46780317 | |
| 0.098 | 0.189 | 0.163 | Dual specificity phosphatase inhibitor | 0.163 0.081 CID_46780317 | CID_46780317 | |
| 0.019 | 0.112 | 0.108 | Beta tubulin antagonist | 0.108 0.02 CID_46780317 | CID_46780317 | |
| 0.061 | 0.167 | 0.235 | Tubulin antagonist | 0.235 0.028 CID_46780317 | CID_46780317 | |
| 0.13 | 0.246 | 0.256 | Beta lactamase inhibitor | 0.256 0.154 CID_154699645 | CID_154699645 | |
| 0.028 | 0.15 | 0.063 | HIV-1 integrase (3'-Processing) inhibitor | 0.063 0.044 CID_46780317 | CID_46780317 | |
| 0.009 | 0.148 | 0.046 | Estradiol 17 beta-dehydrogenase 2 inhibitor | 0.046 0.018 CID_46780317 | CID_46780317 | |
| 0.139 | 0.286 | 0.284 | 15-Lipoxygenase inhibitor | 0.284 0.141 CID_46780317 | CID_46780317 | |
| 0.031 | 0.189 | 0.058 | Heat shock protein 90 beta antagonist | 0.058 0.043 CID_46780317 | CID_46780317 | |
| 0.108 | 0.269 | 0.214 | Lipoxygenase inhibitor | 0.214 0.126 CID_46780317 | CID_46780317 | |
| 0.025 | 0.187 | 0.063 | CXC chemokine 1 receptor antagonist | 0.063 0.018 CID_46780317 | CID_46780317 | |
| 0.027 | 0.193 | 0.078 | Proto-oncogene tyrosine-protein kinase c-hck inhibitor | 0.078 0.055 CID_46780317 | CID_46780317 | |
| 0.104 | 0.313 | 0.188 | Hypoxia-inducible factor 1 alpha inhibitor | 0.188 0.168 CID_46780317 | CID_46780317 | |
| 0.068 | 0.282 | 0.166 | Interleukin antagonist | 0.156 0.114 CID_46780317 0.166 0.107 CID_154699645 | CID_154699645 | |
| 0.148 | 0.362 | 0.352 | Apoptosis agonist | 0.352 0.138 CID_46780317 | CID_46780317 | |
| 0.033 | 0.277 | 0.087 | Bronchodilator | 0.087 0.078 CID_46780317 | CID_46780317 | |
| 0.058 | 0.323 | 0.239 | Antimitotic | 0.239 0.064 CID_46780317 | CID_46780317 | |
| 0.045 | 0.317 | 0.184 | Amyloid beta aggregation inhibitor | 0.184 0.086 CID_46780317 | CID_46780317 | |
| 0.06 | 0.336 | 0.575 | Free radical scavenger | 0.194 0.103 CID_46780317 0.575 0.01 CID_154699645 | CID_154699645 | |
| 0.036 | 0.326 | 0.155 | Lipid peroxidase inhibitor | 0.152 0.067 CID_46780317 0.155 0.065 CID_154699645 | CID_154699645 | |
| 0.014 | 0.409 | 0.193 | 5-Lipoxygenase inhibitor | 0.193 0.026 CID_154699645 | CID_154699645 | |
| 0.031 | 0.534 | 0.273 | Antioxidant | 0.273 0.073 CID_154699645 | CID_154699645 | |
| 0.005 | 0.582 | 0.878 | Peroxisome proliferator-activated receptor gamma agonist | 0.878 0.002 CID_154699645 | CID_154699645 | Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |